Andreoli L - Search Results

1

Trial of Rivaroxaban in AntiPhospholipid Syndrome (TRAPS): Two-year outcomes after the study closure.

Pengo V, Hoxha A, Andreoli L, Tincani A, Silvestri E, Prisco D, Fierro T, Gresele P, Cafolla A, De Micheli V, Ghirarduzzi A, Tosetto A, Falanga A, Martinelli I, Testa S, Barcellona D, Gerosa M, Denas G. Pengo V, et al. Among authors: andreoli l. J Thromb Haemost. 2021 Feb;19(2):531-535. doi: 10.1111/jth.15158. Epub 2020 Nov 29. J Thromb Haemost. 2021. PMID: 33128325 Free article. Clinical Trial.

2

Anti-cardiolipin and anti-beta2-glycoprotein I antibodies: performance of new commercial ELISA kits.

Andreoli L, Malacarne F, Ceribelli A, Kutschera I, Tincani A. Andreoli L, et al. Ann N Y Acad Sci. 2007 Aug;1109:531-7. doi: 10.1196/annals.1398.059. Ann N Y Acad Sci. 2007. PMID: 17785342

3

Inflammatory molecules: a target for treatment of systemic autoimmune diseases.

Tincani A, Andreoli L, Bazzani C, Bosisio D, Sozzani S. Tincani A, et al. Among authors: andreoli l. Autoimmun Rev. 2007 Nov;7(1):1-7. doi: 10.1016/j.autrev.2007.03.001. Epub 2007 Mar 26. Autoimmun Rev. 2007. PMID: 17967717 Review.

4

Antinucleosome antibodies in primary antiphospholipid syndrome: a hint at systemic autoimmunity?

Andreoli L, Pregnolato F, Burlingame RW, Allegri F, Rizzini S, Fanelli V, Radice A, Corace C, Sinico RA, Meroni PL, Tincani A. Andreoli L, et al. J Autoimmun. 2008 Feb-Mar;30(1-2):51-7. doi: 10.1016/j.jaut.2007.11.004. J Autoimmun. 2008. PMID: 18191541

5

Are the current attempts at standardization of antiphospholipid antibodies still useful? Emerging technologies signal a shift in direction.

Andreoli L, Rizzini S, Allegri F, Meroni P, Tincani A. Andreoli L, et al. Semin Thromb Hemost. 2008 Jun;34(4):356-60. doi: 10.1055/s-0028-1085478. Epub 2008 Sep 23. Semin Thromb Hemost. 2008. PMID: 18814069 Review.

6

[Primary antiphospholipid syndrome evolving into systemic lupus erythematosus: may antinucleosome antibodies be predictive?].

Andreoli L, Pregnolato F, Burlingame RW, Fanelli V, Allegri F, Radice A, Corace C, Sinico RA, Tincani A, Meroni PL. Andreoli L, et al. Reumatismo. 2008 Jul-Sep;60(3):185-91. doi: 10.4081/reumatismo.2008.185. Reumatismo. 2008. PMID: 18854879 Free article. Italian.

7

25 years of the antiphospholipid syndrome: lights and shadows on the primary prophylaxis of asymptomatic patients with confirmed positivity of antiphospholipid antibodies.

Andreoli L, Tincani A. Andreoli L, et al. Intern Emerg Med. 2009 Apr;4(2):165-7. doi: 10.1007/s11739-008-0222-3. Epub 2009 Jan 8. Intern Emerg Med. 2009. PMID: 19130174 No abstract available.

8

Neonatal effects of maternal antiphospholipid syndrome.

Tincani A, Rebaioli CB, Andreoli L, Lojacono A, Motta M. Tincani A, et al. Among authors: andreoli l. Curr Rheumatol Rep. 2009 Feb;11(1):70-6. doi: 10.1007/s11926-009-0010-8. Curr Rheumatol Rep. 2009. PMID: 19171114 Review.

9

Methylenetetrahydrofolate reductase polymorphisms and methotrexate: no association with response to therapy nor with drug-related adverse events in an Italian population of rheumatic patients.

Taraborelli M, Andreoli L, Archetti S, Ferrari M, Cattaneo R, Tincani A. Taraborelli M, et al. Among authors: andreoli l. Clin Exp Rheumatol. 2009 May-Jun;27(3):499-502. Clin Exp Rheumatol. 2009. PMID: 19604445

10

[Methylenetetrahydrofolate reductase polymorphisms in methotrexate treatment of rheumatoid arthritis patients. Review of the literature and personal experience].

Taraborelli M, Andreoli L, Archetti S, Ferrari M, Cattaneo R, Tincani A. Taraborelli M, et al. Among authors: andreoli l. Reumatismo. 2009 Apr-Jun;61(2):98-106. doi: 10.4081/reumatismo.2009.98. Reumatismo. 2009. PMID: 19633796 Free article. Review. Italian.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

260 results

Search Page